Grabar Law Office Investigates Claims on Behalf of Shareholders of FMC Corporation (FMC)

Philadelphia, Pennsylvania--(Newsfile Corp. - March 27, 2024) - A recently filed securities fraud class action complaint alleges that FMC Corporation (NYSE: FMC), via certain of its officers and directors, made materially false and/or misleading statements about the Company's business, operations, and prospects including that: (1) the diminishment of patent protection for FMC's flagship products, such as diamides (a class of insecticide), which accounted for almost 40% of FMC's revenues in the past year and an estimated 60+% of reported EBITDA, following legal defeats in key markets including India, China, and Brazil had opened the door to increased competition from generic versions of those products; (2) the Company repeatedly mislead investors about the status of such proceedings and falsely claimed that it did not and would not face generic competition in key markets until 2026 at the earliest; and (3) because of these issues FMC's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Current FMC shareholders who have held FMC stock since prior to November 2, 2022, can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award at no cost to them whatsoever.

If you would like to learn more about this matter, you are encouraged to visit https://grabarlaw.com/the-latest/fmc-shareholder-investigation/, contact Josh Grabar at jgrabar@grabarlaw.com, or Mia Heller at mheller@grabarlaw.com, or call 267-507-6085.

Attorney Advertising Disclaimer

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/203299